Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing.

Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing.

Item
http://www.wikidata.org/entity/Q46501902
Cardiovascular risk stratification in familial hypercholesterolaemiaThe genetics and screening of familial hypercholesterolaemiaImproving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemiaFamilial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyThe UK Paediatric Familial Hypercholesterolaemia Register: preliminary dataCholesterol Levels in Genetically Determined Familial Hypercholesterolaemia in Russian Karelia.Clinical utility gene card for: hyperlipoproteinemia, TYPE II.Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemiaFamilial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.The distribution and characteristics of LDL receptor mutations in China: A systematic reviewRefinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.Exploring Gaps of Family History Documentation in EHR for Precision Medicine -A Case Study of Familial Hypercholesterolemia AscertainmentIdentification and management of familial hypercholesterolaemia: what does it mean to primary care?Commentary: What's so special about familial hypercholesterolaemia?My Approach to the Patient With Familial Hypercholesterolemia.Utility of genetic determinants of lipids and cardiovascular events in assessing risk.Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.Challenges in the care of familial hypercholesterolemia: a community care perspective.Statins for children with familial hypercholesterolemia.Familial Hypercholesterolaemia in the Era of Genetic Testing.Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolaemia is not a good idea.Knowns and unknowns in the care of pediatric familial hypercholesterolemia.Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia.The detection of heterozygous familial hypercholesterolemia in Ireland.2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document.Genetic Analysis of Iranian Patients with Familial HypercholesterolemiaMutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade projectFamilial Hypercholesterolaemia Diagnosis and ManagementDesign of a Controlled Trial of Cascade Screening for Hypercholesterolemia: The (CASH) Study
P2860
Q26749104-434E6D23-0109-45EE-AA30-A15C4BE32BD9Q26753081-345E79EF-8180-4D67-BA80-7EAC9C530061Q26828780-58F0DB78-3F30-4C09-B377-A1AFD3082D70Q27024882-5E948D2B-96CE-499A-971F-DACCC2715133Q31053814-9C8C711E-2651-44CB-B85A-C092ED58ED98Q33552173-9B6871E3-F601-44E2-A6D3-2BBACBCFDCE8Q33765255-462B7E11-1A62-40F9-BBAE-68FB44B0A877Q34334828-E9EB994C-1ACD-44C1-B271-95280A1358E6Q36076131-4365E115-22A1-48B0-8AD3-D802F9AB0A9AQ36320640-6CF1AF61-5C57-49D7-B659-D81BD602CBB7Q36966952-F19ECC82-5B77-4AD4-A029-2FB4C49F0681Q37211293-CDBA6974-0DED-4238-8379-630EAD903993Q37362738-C0A52094-8C20-4947-A11A-CB90594ECBD5Q37362741-3D439412-91AC-4C16-8EBB-04233252BB67Q37731770-4BDDED7B-1504-46DC-91EA-1EA92257A68BQ37842125-94680AC1-6F4F-4D64-A267-AE8096E55CB4Q38132257-05B7B2A7-8451-44D6-8A2B-706FDB6CACECQ38575066-84BBAC86-A180-4FCC-96F3-2AB424BB7ADDQ38689931-DC3F2A21-B692-4141-B6FE-A7782F028E8DQ38784635-666C33E5-CB6E-4F17-9288-CBC5FB1BF91CQ38793246-0DB6232A-6EED-4583-AB88-02CF64C3259EQ39431228-2C362BBA-9D60-48CE-B4C3-2CD3FB03C41AQ41491032-B00F53F1-B937-4D58-9372-910CFA9EE324Q43187323-6948DF44-8B61-4B00-B8C9-C70B5DB5900FQ43718154-1E7B28CC-E706-4C13-8CBD-6724C80530B2Q48123127-67CF36D6-F2D8-4845-B9F0-AC8E7304D1ADQ50337384-F6310804-C363-4F6A-B139-B8145BFBA5B7Q57316565-9877284D-0BF5-4D4B-9409-535FC870467AQ57495857-727E0471-98D6-48A0-AE7B-47939D279F45Q58710131-A71B3413-9533-4832-935B-0EA0D0329C41
P2860

Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing.

Item
http://www.wikidata.org/entity/Q46501902
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Development of sensitive and s ...... terolaemia in cascade testing.
@en
Development of sensitive and s ...... terolaemia in cascade testing.
@nl
type
label
Development of sensitive and s ...... terolaemia in cascade testing.
@en
Development of sensitive and s ...... terolaemia in cascade testing.
@nl
prefLabel
Development of sensitive and s ...... terolaemia in cascade testing.
@en
Development of sensitive and s ...... terolaemia in cascade testing.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Development of sensitive and s ...... terolaemia in cascade testing.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921